Enhanced systemic matrix metalloproteinase response in helicobacter pylori gastritis

Annals of Medicine

Volumn 41, Issue 3, 2009, Pages 208-215

  Rautelin, Hilpi I ^a   Oksanen, Aino M ^b   Veijola, Lea I ^b   Sipponen, Pentti I ^c   Tervahartiala, Taina I ^d   Sorsa, Timo A ^d   Lauhio, Anneli ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Herttoniemi Hospital   (Finland)

^c JORVI HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Gastritis; Helicobacter pylori; Infection; Matrix metalloproteinase

Indexed keywords

GELATINASE A; GELATINASE B; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; MATRILYSIN; MATRIX METALLOPROTEINASE; PEROXIDASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROSCOPY; HELICOBACTER INFECTION; HUMAN; MALE; PRIORITY JOURNAL; STOMACH MUCOSA; BLOOD; ENZYMOLOGY; GASTRITIS; HELICOBACTER PYLORI; METABOLISM; MICROBIOLOGY; MIDDLE AGED; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LEUKOCYTE ELASTASE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, SECRETED; MIDDLE AGED; PEROXIDASE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

EID: 67650360228     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.1080/07853890802482452     Document Type: Article

References (41)

1. Malfertheiner P, Megraud F, O?Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-781. (Pubitemid 46854190)
2. Sobala G, Crabtree J, Dixon M, Schorah C, Taylor J, Rathbone B, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut. 1991;32:1415-1418.
3. Kosunen TU, Aromaa A, Knekt P, Salomaa A, Rautelin H, Lohi P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect. 1997;119:29-34.
4. Egeblad M, Werb Z. New functions for the matrix metallo-proteinases in cancer progression. Nat Rev Cancer. 2002;2:161-174.
5. Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38:306-321.
6. McMillan SJ, Kearley J, Campbell JD, Zhu XW, Larbi KY, Shipley JM, et al. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol. 2004;172:2586-2594.
7. Elkington PTG, O?Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol. 2005;142:12-20.
8. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol. 2002;3:207-214.
9. Hartog CM, Wermelt JA, Sommerfeld CO, Eichler W, Dalhoff K, Braun J. Pulmonary matrix metalloproteinase excess in hospital-acquired pneumonia. Am J Respir Crit Care Med. 2003;167:593-598.
10. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002;115:3719-3727.
11. Bodger K, Ahmed S, Pazmany L, Pritchard DM, Michael A, Khan AL, et al. Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine Helicobacter infection. J Clin Pathol. 2008;61:72-78.
12. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365-376.
13. Geraghty P, Rogan MP, Greene CM, Boxio RMM, Poiriert T, O?Mahony M, et al. Neutrophil elastase up-regulates cathepsin B and matrix metalloproteinase-2 expression. J Immunol. 2007;178:5871-5878.
14. Wang Y, Rosen H, Madtes DK, Shao B, Martin TR, Heinecke JW, et al. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue. J Biol Chem. 2007;282:31826-31834.
15. Hellmig S, Ott S, Rosenstiel P, Folsch UR, Hampe J, Schreiber S. Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. pylori infection. Am J Gastroenterol. 2006;101:29-35.
16. Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimaki A, Haglund C. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J Clin Pathol. 2006;59:618-623.
17. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, et al. Expression of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric cancer. Anticancer Res. 2006;26:3579-3583.
18. Bergin PJ, Edebo A, Wen S, Johnsson E, Andersson J, Lonroth H, et al. Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis. Helicobacter. 2004;9:201-210.
19. Koyama S. Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pylori-associated gastritis. Scand J Gastroenterol. 2004;39:1046-1053.
20. Yanagisawa N, Geironson L, Al-Soud WA, Ljungh A. Expression of matrix metalloproteinase-2, -7, -9 on human colon, liver and bile duct cell lines by enteric and gastric Helicobacter species. FEMS Immunol Med Microbiol. 2004;44:197-204.
21. Kundu P, Mukhopadhyay AK, Patra R, Banerjee A, Berg DE, Swarnakar S. Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem. 2006;281:34651-34662.
22. Oliveira MJ, Costa AC, Costa AM, Henriques L, Suriano G, Atherton J, et al. Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner. J Biol Chem. 2006;281:34888-34896.
23. Bebb JR, Letley DP, Thomas RJ, Aviles F, Collins HM, Watson SA, et al. Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner. Gut. 2003;52:1408-1413.
24. Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM. Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology. 2003;125: 1125-1136.
25. Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, Wada A, et al. Helicobacter pylori induces matrix metallo-proteinase-9 through activation of nuclear factor KB. Gastroenterology. 2003;124:983-992.
26. Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, Lin JT, et al. Helicobacter pylori promote gastric cancer cell invasion through a NF-kappaB and COX-2-mediated pathway. World J Gastroenterol. 2005;11:3197-3203.
27. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181.
28. Bergmann U, Michaelis J, Oberhoff R, Knauper V, Beck-mann R, Tschesche H. Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase. J Clin Chem Clin Biochem. 1989;27:351-359.
29. Lauhio A, Konttinen YT, Tschesche H, Nordstrom D, Salo T, Lahdevirta J, et al. Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis. Antimicrob Agents Chemother. 1994;38:400-402.
30. Bergin PJ, Wen S, Pan-Hammarstrom Q, Quiding-Jarbrink M. Secretion of matrix metalloproteinase-9 by macrophages, in vitro, in response to Helicobacter pylori. FEMS Immunol Med Microbiol. 2005;45:159-169.
31. Yokoyama T, Otani Y, Kurihara N, Sakurai Y, Kameyama K, Suzuki H, et al. Matrix metalloproteinase expression in cultured human gastric wall fibroplasts-interactions with Helicobacter pylori isolated from patients with ulcers. Aliment Pharmacol Ther. 2000;14:193-198.
32. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science. 2000;289:1202-1206.
33. Dozier S, Escobar GP, Lindsey ML. Matrix metalloproteinase (MMP)-7 activates MMP-8 but not MMP-13. Med Chem. 2006;2:523-526.
34. Pasceri V, Patti G, Cammarota G, Pristipino C, Richichi G, Di Sciascio G. Virulent strains of Helicobacter pylori and vascular diseases: a meta analysis. Am Heart J. 2006;151: 1215-1222.
35. Danese S, Papa A, Ricci R, Maggiano N. Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer. Gastroenterology. 2004;126:369-371.
36. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998;32:368-372.
37. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003; 107:1579-1585.
38. Lint VP, Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev. 2006;17:217-223.
39. Tuomainen AM, Nyyssonen K, Laukkanen JA, Tervahartiala T, Tuomainen TP, Salonen JT, et al. Serum matrix metallo-proteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscl Tromb Vasc Biol 2007; 27:2722-2728.
40. Kubben FJGM, Sier CFM, Meijer MJW, van den Berg M, van der Reijden JJ, Griffioen G, et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer. 2006;95:744-751.
41. Torii A, Kodera Y, Uesaka K, Hirai T, Yasui K, Morimoto T, et al. Plasma concentration of matrix metalloproteinase 9 in gastric cancer. Br J Surg. 1997;84:133-136pp